Imapextide

Imapextide is a glucagon-like peptide-1 (GLP-1) receptor antagonist that can be used in hypoglycemia research[1].

3004569-93-8

MBX 1416

12352209

GLP Receptor

GPCR/G Protein

Metabolism-protein/nucleotide metabolism

Metabolic Disease

O=C([C@@H](NC(CCCCCCCCCCCCCCCCC(O)=O)=O)CC(O)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N1[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N2[C@H](C(N3[C@H](C(N4[C@H](C(N[C@H](C(O)=O)CO)=O)CCC4)=O)CCC3)=O)CCC2)=O)C)=O)=O)CO)=O)CO)=O)CCC1)=O)=O)=O)CCCNC(N)=N)=O)C(C)C)=O)CC(C)C)=O)CC5=CNC6=CC=CC=C56)=O)C)=O)[C@H](CC)C)=O)CC7=CC=CC=C7)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)C(C)C)=O)C)=O)CCC(N)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)CC(C)C)=O)CC8=CC=C(O)C=C8)=O)CO)=O)CO)=O)C(C)C

C166H257N39O50

3599.05

[1]WHO. International Nonproprietary Names for Pharmaceutical Substances (INN), Proposed International Nonproprietary Names: List 132. WHO Drug Information, Vol. 38 , No. 4, 2024.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P10957/

Peptides

No Development Reported